Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
1 Online-Ressource.
Sprache
Englisch

Erschienen in
Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma ; volume:12 ; number:1 ; day:20 ; month:7 ; year:2024 ; pages:1-15 ; date:12.2024
Biomarker Research ; 12, Heft 1 (20.7.2024), 1-15, 12.2024

Urheber
Anderson, Ashley N.
Conley, Patrick
Klocke, Christopher D.
Sengupta, Sidharth K.
Pang, Amara
Farley, Hannah C.
Gillingham, Abigail R.
Dawson, Aubrey D.
Fan, Yichen
Jones, Jocelyn A.
Gibbs, Summer L.
Skalet, Alison H.
Wu, Guanming
Wong, Melissa H.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s40364-024-00609-6
URN
urn:nbn:de:101:1-2410062102042.008811377394
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:28 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Anderson, Ashley N.
  • Conley, Patrick
  • Klocke, Christopher D.
  • Sengupta, Sidharth K.
  • Pang, Amara
  • Farley, Hannah C.
  • Gillingham, Abigail R.
  • Dawson, Aubrey D.
  • Fan, Yichen
  • Jones, Jocelyn A.
  • Gibbs, Summer L.
  • Skalet, Alison H.
  • Wu, Guanming
  • Wong, Melissa H.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis

Novel treatment paradigms for metastatic uveal melanoma

Novel treatment paradigms for metastatic uveal melanoma

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

The immune cell landscape of metastatic uveal melanoma correlates with overall survival

The immune cell landscape of metastatic uveal melanoma correlates with overall survival

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Pembrolizumab as first-line treatment for metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

The Current State of Systemic Therapy of Metastatic Uveal Melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

Clinical determinants of long-term survival in metastatic uveal melanoma

The Role of Immune Checkpoint Blockade in Uveal Melanoma

The Role of Immune Checkpoint Blockade in Uveal Melanoma

Verbundene Objekte